

# **Molecular Dissection of AcrF8: A Novel Anti-CRISPR Strategy in Pectobacterium Phage ZF40**

## **Executive Summary**

This report provides an exhaustive analysis of the anti-CRISPR (Acr) protein AcrF8, a key component in the immune evasion arsenal of the temperate bacteriophage ZF40. This phage infects the significant plant pathogen *Pectobacterium carotovorum*, the causative agent of soft rot diseases in numerous crops. The continuous evolutionary arms race between bacteria and their viral predators has driven the development of sophisticated defense and counter-defense systems. Within this context, AcrF8 represents a unique and highly evolved molecular weapon. This analysis delves into the intricate mechanism of CRISPR-Cas inhibition employed by AcrF8, identifies the structural domains and specific interactions that confer its function, and elucidates the elegant regulatory network that governs its expression.

Structural and biochemical data reveal that AcrF8 neutralizes the host's Type I-F CRISPR-Cas immune system through a novel mechanism not previously observed in other anti-CRISPRs targeting this system. It functions by binding directly to the crRNA-guided surveillance (Csy) complex, engaging both the protein backbone and, uniquely, the CRISPR RNA (crRNA) scaffold. This dual-targeting strategy effectively locks the complex in an inactive state, preventing it from recognizing and binding to the phage's DNA.

Furthermore, the expression of AcrF8 is precisely controlled. It is encoded in an operon with its dedicated transcriptional repressor, the anti-CRISPR-associated (Aca) protein Aca2. This genetic architecture facilitates a "fast on, fast off" expression profile, ensuring a rapid burst of AcrF8 production upon infection to overwhelm host defenses, followed by swift repression to prevent deleterious effects associated with its overexpression. By synthesizing structural, genetic, and comparative biological data, this report constructs a comprehensive model of AcrF8 function, highlighting it as a paradigm of viral co-evolution and a potential tool for the development of next-generation biotechnological applications requiring precise control over CRISPR-based technologies.

## **The Battlefield: CRISPR-Cas Immunity in Pectobacterium**

### **The Host: Pectobacterium as a Phytopathogen and the ZF40 Host Identity**

The biological stage for the function of AcrF8 is the interaction between a bacteriophage and its bacterial host, a member of the genus *Pectobacterium*. These Gram-negative, facultative anaerobic bacteria are formidable plant pathogens, belonging to the family *Pectobacteriaceae*.1 They are the etiological agents of debilitating agricultural diseases, including soft rot and blackleg, which affect a vast range of economically critical crops such as potatoes, carrots, tomatoes, and onions.2 The significant virulence of

*Pectobacterium* species stems from their capacity to secrete a powerful arsenal of plant cell wall-degrading enzymes (PCWDEs), including pectinases, cellulases, and proteases. These enzymes macerate plant tissue, leading to the characteristic rot and causing substantial pre- and post-harvest losses worldwide.1

The specific host for the bacteriophage ZF40, which encodes AcrF8, has been reported with some inconsistency in the literature. Several early bioinformatic studies that led to the discovery of the *acrF8* gene listed the host as *Pectobacterium atrosepticum*.7 However, a greater weight of evidence from primary phage characterization studies, genomic sequencing databases, and structural biology reports consistently identifies the host as

*Pectobacterium carotovorum*.8 While

*P. atrosepticum* and *P. carotovorum* are closely related species with distinct pathological profiles, the Cas proteins of their respective Type I-F systems share significant sequence identity (40% to 60%).7 This suggests that AcrF8 may possess a degree of cross-species inhibitory activity, a common feature among some Acr proteins.17 For the purposes of this report,

*P. carotovorum* will be considered the definitive host.

Phage ZF40 is a temperate Myoviridae phage, a classification that is central to understanding the evolutionary pressures that shaped its anti-CRISPR system.8 Unlike strictly lytic phages that only replicate and destroy their host, temperate phages can pursue an alternative lysogenic life cycle. In lysogeny, the phage genome integrates into the host's chromosome, becoming a dormant "prophage" that is replicated along with the bacterial DNA.8 This dual-lifestyle capability imposes a unique challenge. A lytic phage must only suppress the host's CRISPR-Cas system for the duration of one infection cycle. A temperate phage, however, must ensure the long-term stability of its integrated prophage. If the host's CRISPR-Cas system were to acquire a spacer sequence targeting the prophage DNA, it would lead to the cleavage of its own chromosome. This self-targeting is a form of autoimmunity that is typically lethal to the bacterial cell.18 Consequently, for a temperate phage like ZF40, the AcrF8 protein is not merely a tool for initial invasion but a critical factor for establishing and maintaining a stable lysogenic state. It must provide a robust and lasting inactivation of the CRISPR surveillance machinery to prevent the host from self-destructing after lysogenization, thereby ensuring the survival of the phage's genetic lineage within the host population.

### **The Defense System: Architecture of the Type I-F CRISPR-Cas System**

To appreciate the mechanism of AcrF8, it is essential to first understand the molecular machinery it targets. *Pectobacterium* employs a Type I-F CRISPR-Cas system, which is a member of the Class 1 CRISPR systems that utilize multi-protein effector complexes for defense.19 The interference stage of this system, where invading DNA is recognized and destroyed, is mediated by a sophisticated ribonucleoprotein assembly known as the crRNA-guided surveillance complex, or Csy complex.21

The Csy complex is assembled with a precise stoichiometry and architecture. Its core is a helical backbone formed by six subunits of the Cas7f protein (also known as Csy3). These subunits bind along the variable spacer region of a mature CRISPR RNA (crRNA), which serves as the guide to identify foreign DNA.23 The complex is capped at one end by a "head" subunit, Cas6f (Csy4), which is an endoribonuclease responsible for processing the precursor crRNA transcript and remains bound to the 3' repeat-handle of the mature crRNA.20 At the other end is a "tail" subunit, which is a heterodimer of Cas8f (Csy1) and Cas5f (Csy2). This tail dimer binds to the 5' repeat-handle of the crRNA and is responsible for the initial recognition of the target DNA.20

The function of the fully assembled Csy complex is to patrol the cell's interior, searching for DNA sequences that are complementary to its crRNA guide. For successful recognition, the target sequence (protospacer) must be adjacent to a short, specific sequence known as the Protospacer Adjacent Motif (PAM).25 The PAM serves as a key recognition element that helps the system distinguish foreign DNA from the host's own CRISPR locus, which contains the same spacer sequences but lacks the PAM. Upon binding to a PAM-flanked protospacer, the Csy complex undergoes a significant conformational change. This structural rearrangement creates a binding site for the recruitment of the final effector protein, the Cas2/3 nuclease-helicase.20 Once recruited, Cas2/3 unwinds the target DNA and systematically degrades it, effectively neutralizing the invading phage genome. Any successful anti-CRISPR protein must therefore disrupt one of these critical steps: the assembly of the Csy complex, its ability to bind target DNA, or its capacity to recruit the Cas2/3 nuclease.

## **The Weapon: AcrF8's Unique Inhibitory Mechanism**

### **Discovery and Genomic Locus**

The identification of AcrF8 was a testament to the power of bioinformatics in uncovering novel biological functions. Unlike the first anti-CRISPRs, which were found through functional screens of phages that could overcome CRISPR-based immunity, AcrF8 was discovered using a "guilt-by-association" strategy.7 Early research into Acr proteins revealed that their genes are frequently located in the genome adjacent to a set of conserved genes named anti-CRISPR-associated (

*aca*) genes.10 These

*aca* genes often encode transcriptional regulators for the *acr* genes themselves.

This conserved genetic linkage provided a powerful predictive tool. Researchers first identified a conserved *aca* gene, *aca1*, in *Pseudomonas* phages and used its sequence to search other phage and prophage genomes. This approach successfully identified new *acr* genes. In the process, a second, distinct family of associated regulators was discovered and named *aca2*. By using the *aca2* gene sequence as a new bioinformatic query, scientists were able to uncover an entirely new set of putative anti-CRISPR genes in a diverse range of bacterial and phage genomes, including *acrF8* in *Pectobacterium* phage ZF40.7

The *acrF8* gene (locus tag: gp31; protein accession: YP\_007006940.1) is located within the 48 kb genome of phage ZF40 (RefSeq: NC\_019522).7 It encodes a small, acidic protein of 92 amino acids with a predicted molecular weight of 10.2 kDa and a theoretical isoelectric point (pI) of 5.36.11 Genomically,

*acrF8* is situated immediately upstream of its cognate regulatory gene, *aca2* (locus tag: ZF40\_0030), forming a co-transcribed unit known as the *acrF8-aca2* operon.10 This tight genetic linkage is the basis of its discovery and is fundamental to its biological regulation.

### **Structural Basis of Inhibition**

The molecular mechanism of AcrF8 was definitively revealed by a cryo-electron microscopy (cryo-EM) study that solved the structure of AcrF8 in complex with the *P. aeruginosa* Csy complex to a resolution of 3.42 Å.11 The resulting structural model, available in the Protein Data Bank (PDB) under accession code 6VQW and in the Electron Microscopy Data Bank (EMDB) as EMD-21359, provides a detailed atomic snapshot of the inhibitory interaction.30

The structure shows that AcrF8 functions as a monomer, binding one-to-one with the Csy complex.11 Its binding site is located on the convex surface of the helical backbone formed by the six Cas7f subunits.21 This binding location is distinct from that of many other characterized Type I-F Acrs, which often target the Cas8f/Cas5f "tail" or the Cas3 nuclease directly. By targeting the central backbone of the surveillance complex, AcrF8 effectively disrupts the component responsible for guiding the crRNA and interacting with the target DNA along its length. Structure-guided mutagenesis experiments, detailed in the primary publication associated with PDB entry 6VQW, have identified the specific amino acid residues on the surface of AcrF8 that are critical for this interaction. These residues form a network of hydrogen bonds and hydrophobic contacts with both the Cas7f protein subunits and the crRNA, anchoring AcrF8 firmly to its target.

### **A Novel Mode of Action: Direct crRNA Engagement**

The most remarkable and defining feature of AcrF8's inhibitory mechanism is its ability to engage with both the protein and RNA components of the Csy complex. While it makes extensive contact with the Cas7f protein backbone, it simultaneously forms critical interactions with the phosphate backbone of the crRNA that is cradled within the Csy complex.21 This mode of action is explicitly noted as being unique among all characterized Acr proteins that target the Csy complex.21

This dual-targeting strategy provides a profound functional advantage. By binding to both protein and RNA, AcrF8 acts as a molecular "clamp" or "staple," locking the Csy complex into a rigid, inactive conformation. The process of target DNA recognition and binding by the Csy complex requires significant conformational flexibility, allowing the complex to open and accommodate the invading DNA to form an R-loop (a structure where the DNA strand is displaced by the crRNA). The clamping action of AcrF8 likely prevents these necessary structural rearrangements, thereby physically and allosterically blocking the DNA binding site.

This unique mechanism represents a sophisticated evolutionary strategy for achieving high-potency inhibition. An inhibitor that targets only a single protein-protein interface can be rendered ineffective if the host evolves mutations at that interface. The crRNA backbone, however, is a structurally conserved and chemically repetitive element that is fundamental to the assembly and function of the entire complex. By evolving to recognize and bind to both a protein surface and this essential RNA scaffold, AcrF8 creates a larger, more complex binding interface. This multi-pronged interaction likely increases the overall binding affinity and, more importantly, presents a much greater evolutionary hurdle for the host to overcome. To escape inhibition by AcrF8, the host's CRISPR-Cas system would need to co-evolve mutations in both its Cas7f protein and the fundamental structure of its crRNA backbone, a far more complex and constrained evolutionary path than altering a single protein surface. This makes AcrF8 a particularly robust and durable inhibitor, ensuring the phage's counter-attack remains effective against a co-evolving host defense system.

### **Comparative Analysis of Type I-F Anti-CRISPRs**

To fully contextualize the novelty of AcrF8, its mechanism must be viewed within the broader landscape of phage-encoded inhibitors targeting the Type I-F system. Phages have evolved a remarkable diversity of molecular strategies to achieve the same convergent goal: the inactivation of CRISPR-Cas immunity. These strategies can be broadly categorized into two major groups based on the stage of the interference pathway they disrupt.11

The first group consists of inhibitors that prevent the Csy complex from binding to its target DNA. These proteins function by sterically occluding the DNA binding site or by locking the complex in a conformation that is incompatible with DNA recognition. AcrF8 falls into this category, but it shares this general function with several other Acrs that use different binding sites and molecular interactions. For example, AcrIF1 and AcrIF2 bind to the Cas8f-Cas5f "tail" of the complex, blocking the initial site of DNA engagement.23 AcrIF9 also binds along the Cas7f backbone, but it does so by mimicking the phosphate backbone of the target DNA, acting as a molecular decoy.21 AcrIF6 targets a specific junction between the Cas7f backbone and the Cas8f tail, a site that is critical for separating the two strands of the target DNA duplex.21

The second group of inhibitors allows the Csy complex to bind to the target DNA but prevents the final, destructive step of nuclease recruitment and DNA degradation. The archetypal member of this group is AcrIF3, which completely ignores the Csy complex and instead binds directly to the Cas2/3 nuclease. This interaction sequesters Cas2/3, preventing it from ever being recruited to the DNA-bound Csy complex, thereby aborting the immune response at the final step.22

The following table summarizes the mechanisms of several well-characterized Type I-F anti-CRISPR proteins, highlighting the distinct strategy employed by AcrF8.

| Acr Protein Family | Source Organism/Phage | Molecular Target | Mechanism of Inhibition | Unique Feature |
| :---- | :---- | :---- | :---- | :---- |
| **AcrIF1** | *P. aeruginosa* phage JBD30 | Cas8f-Cas5f | Binds to the "tail" of the Csy complex, blocking target DNA binding.11 | Targets the DNA-recognition subunit. |
| **AcrIF2** | *P. aeruginosa* phage MP29 | Cas8f-Cas5f | Binds to the "tail" of the Csy complex, blocking target DNA binding.11 | Competes with AcrIF1 for a similar binding region. |
| **AcrIF3** | *P. aeruginosa* phage JBD88a | Cas2/3 Nuclease | Binds directly to the Cas2/3 nuclease, preventing its recruitment to the Csy-DNA complex.11 | Allows DNA binding but blocks the final cleavage step. |
| **AcrIF6** | *P. aeruginosa* prophage | Cas7f/Cas8f Junction | Binds at a critical interface required for splitting the target DNA duplex, thus blocking R-loop formation.11 | Targets a key conformational checkpoint. |
| **AcrIF8** | *Pectobacterium* phage ZF40 | Cas7f Backbone & crRNA | Binds to the Cas7f protein backbone and directly interacts with the crRNA backbone, locking the complex.11 | **Directly engages the crRNA scaffold, a mechanism not seen in other Type I-F Acrs.** |
| **AcrIF9** | *V. parahaemolyticus* prophage | Cas7f Backbone | Binds to key DNA-binding sites along the Cas7f backbone, acting as a DNA mimic to occlude the target.11 | Functions as a molecular decoy for target DNA. |
| **AcrIF10** | *S. xiamenensis* prophage | Cas8f-Cas5f | Binds to the Csy complex "tail," preventing DNA binding through a distinct interface from AcrIF1/IF2.11 | Demonstrates convergent evolution on the same target subunit. |

This comparative analysis underscores the remarkable evolutionary plasticity of anti-CRISPR proteins. While all these proteins effectively neutralize the Type I-F system, they achieve this through a wide variety of structural and mechanistic solutions. The crRNA-engaging mechanism of AcrF8 is a clear example of this diversity and represents a distinct and highly effective evolutionary trajectory in the ongoing conflict between phages and their bacterial hosts.

## **The Control Switch: Transcriptional Regulation via the Aca2 Repressor**

### **The acrF8-aca2 Operon: A "Fast On, Fast Off" System**

The deployment of a potent weapon like AcrF8 requires precise control. Upon injection of its DNA into the host cell, the phage must rapidly produce AcrF8 to neutralize the pre-existing Csy complexes before they can target the phage genome. This is achieved by expressing the *acr* gene from a strong, early promoter.18 However, the continued, high-level expression of an anti-CRISPR protein can be detrimental. It may interfere with the phage's own replication machinery, be metabolically costly, or even be toxic to the host cell upon which the phage depends for propagation.27 Therefore, an ideal system would enable a rapid burst of expression followed by a swift shutdown once the initial threat has been neutralized.

Phage ZF40 achieves this sophisticated temporal control through the genetic architecture of the *acrF8-aca2* operon.10 By placing the gene for the inhibitor (

*acrF8*) and the gene for its own transcriptional repressor (*aca2*) under the control of a single promoter, the phage creates a self-regulating negative feedback loop. This "fast on, fast off" strategy ensures that the production of AcrF8 is inherently self-limiting, providing a simple yet elegant solution to the phage's regulatory dilemma.18 This compact, self-contained module is a hallmark of the genomic economy that characterizes viral evolution, allowing the phage to execute a complex, time-dependent gene expression program with a minimal amount of genetic code.

### **Aca2 Structure and Function**

The molecular details of this regulatory switch have been elucidated by the high-resolution crystal structure of the Aca2 protein from phage ZF40, which was solved by X-ray crystallography to 1.31 Å (PDB: 7VJO).10 The structure reveals that Aca2 functions as a homodimer, a common feature of DNA-binding regulatory proteins.10 Each Aca2 monomer is composed of two distinct functional domains that are critical for its role as a repressor.35

The first is a conserved N-terminal helix-turn-helix (HTH) DNA-binding domain. The HTH motif is one of the most common DNA-binding motifs found in prokaryotic transcription factors. It consists of two α-helices joined by a short loop; one helix (the recognition helix) fits into the major groove of the DNA, where it can make base-specific contacts, while the other helix helps to position the recognition helix correctly.35

The second is a previously uncharacterized C-terminal dimerization domain. This domain is responsible for bringing two Aca2 monomers together to form the functional dimeric repressor. The structural arrangement of the dimer is crucial, as it positions the two N-terminal HTH domains with the precise spacing and orientation required to simultaneously engage two recognition sites on the palindromic operator DNA sequence.35 Without dimerization, the protein would be unable to bind to its target DNA with high affinity and specificity.

### **The Repression Mechanism: Aca2-Promoter Interaction**

Aca2 functions as a classic transcriptional autorepressor.10 As the

*acrF8-aca2* operon is transcribed and translated, the concentration of Aca2 protein in the cell begins to rise. Once a sufficient concentration is reached, Aca2 monomers dimerize and bind with high affinity to a specific operator sequence located within the promoter region of the operon.10 The primary literature describing the Aca2-DNA complex structure reveals that this operator is a palindromic DNA sequence, perfectly suited for binding by the symmetric Aca2 dimer. Specific amino acid residues within the recognition helices of the HTH domains make direct, base-specific contacts within the major grooves of this operator DNA, ensuring the interaction is both strong and highly specific.

By binding to this operator site, the Aca2 dimer physically obstructs the promoter. This steric hindrance prevents the host cell's RNA polymerase from binding to the promoter and initiating transcription.36 As a result, the production of new

*acrF8* and *aca2* mRNA is halted, effectively shutting down the system. This negative feedback loop ensures that AcrF8 is produced in a rapid, self-limiting burst, providing just enough inhibitor to overcome the host's defenses without leading to prolonged, detrimental expression.

## **Synthesis and Broader Implications**

### **The Co-evolutionary Narrative of Phage ZF40 and its Host**

The AcrF8-Aca2 system of phage ZF40 is more than just a collection of interacting molecules; it is a finely tuned tactical module that provides a compelling snapshot of the co-evolutionary arms race between a virus and its host. The development of a Type I-F CRISPR-Cas system by *Pectobacterium* provided the bacterium with a powerful adaptive defense against phage predation. In response, phage ZF40 evolved the AcrF8 protein, a potent countermeasure. The unique crRNA-binding mechanism of AcrF8 may have arisen as a specific adaptation to counter the particular structural features of the *Pectobacterium* Csy complex, making it a highly specialized weapon in this specific conflict.

The evolution of this potent inhibitor, however, created a new problem for the phage: the need for precise control. This selective pressure led to the evolution of the Aca2 repressor and its integration into the *acrF8* locus, creating a self-regulating operon. This entire module is further shaped by the temperate lifestyle of ZF40. The need to maintain a stable, long-term lysogenic relationship without triggering lethal host autoimmunity likely provided the ultimate selective pressure for a system that is not just effective, but also perfectly regulated. The AcrF8-Aca2 system thus represents a sophisticated and integrated solution that is critical to the phage's overall survival strategy.

### **Biotechnological Horizons: AcrF8 as a Tool for Genome Engineering**

The ongoing discovery and characterization of diverse anti-CRISPR proteins have significant implications beyond evolutionary biology, opening new avenues for biotechnology.11 While CRISPR-Cas systems, particularly the Class 2 Cas9 and Cas12 proteins, have revolutionized genome editing, a major challenge remains the precise control of their activity. Uncontrolled or prolonged Cas nuclease activity can lead to off-target mutations and chromosomal abnormalities, raising safety concerns for therapeutic applications.19 Acr proteins are nature's "off-switches" and provide a powerful means to mitigate these risks.38

As biotechnology expands to include the more complex Class 1 CRISPR systems for applications like large-scale genome engineering or multiplexed gene regulation, the need for corresponding inhibitors will grow. AcrF8, as a potent and highly specific inhibitor of the Type I-F system, is a prime candidate for development as a controllable safety switch for any technologies based on this system.

Moreover, the naturally evolved regulatory circuit of the *acrF8-aca2* operon provides a blueprint for designing more sophisticated control systems. Instead of relying solely on an externally inducible promoter to turn AcrF8 expression on or off, one could engineer a synthetic circuit that incorporates the Aca2-based negative feedback loop. Such a system could provide a self-limiting dose of the inhibitor, offering a more nuanced and potentially safer level of control than a simple binary switch. The engineering of light- and ligand-inducible Acrs has already demonstrated the value of reversible and spatiotemporally controlled inhibition.17 The AcrF8/Aca2 pair offers a naturally perfected, self-regulating module that could be adapted to build the next generation of safe and precise CRISPR-based tools.

## **Conclusion**

The anti-CRISPR protein AcrF8 from *Pectobacterium* phage ZF40 is a remarkable product of viral evolution, showcasing a novel and highly effective mechanism for neutralizing host adaptive immunity. Through detailed structural and genetic analysis, its function can be understood on three distinct levels:

1. **Mechanism:** AcrF8 inhibits the host Type I-F CRISPR-Cas system by binding to the central backbone of the Csy surveillance complex. Its mechanism is distinguished by a unique dual-targeting strategy, engaging both the Cas7f protein subunits and the crRNA scaffold, thereby locking the complex in an inactive state and preventing target DNA binding.  
2. **Structure-Function:** The protein functions as a monomer, utilizing a specific surface patch to create an extensive binding interface with its target. This dual protein-RNA interaction likely confers high-potency inhibition and makes the inhibitor more resilient to host co-evolutionary escape.  
3. **Regulation:** The expression of AcrF8 is elegantly controlled by a self-regulating negative feedback loop. It is co-expressed with its dedicated transcriptional repressor, Aca2, which shuts down the operon once a sufficient concentration is reached, ensuring a "fast on, fast off" deployment strategy that is critical for the phage's life cycle.

Together, the AcrF8-Aca2 module represents a sophisticated and compact solution to the challenge of overcoming host defenses. Its study not only provides profound insights into the molecular dynamics of the prokaryote-phage arms race but also offers valuable molecular components for the development of safer and more controllable CRISPR-based technologies.

#### **Works cited**

1. Microbe Profile: Pectobacterium atrosepticum: an enemy at the door \- Microbiology Society, accessed September 7, 2025, [https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.001221?crawler=true\&mimetype=application/pdf](https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.001221?crawler=true&mimetype=application/pdf)  
2. Pectobacterium carotovorum \- Wikipedia, accessed September 7, 2025, [https://en.wikipedia.org/wiki/Pectobacterium\_carotovorum](https://en.wikipedia.org/wiki/Pectobacterium_carotovorum)  
3. Comparative genomic analysis of Pectobacterium carotovorum subsp. brasiliense SX309 provides novel insights into its genetic and phenotypic features \- PMC, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC6567464/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6567464/)  
4. DIVERSITY OF Pectobacterium STRAINS BY BIOCHEMICAL, PHYSIOLOGICAL, AND MOLECULAR CHARACTERIZATION DIVERSIDADE \- FI-Admin, accessed September 7, 2025, [https://fi-admin.bvsalud.org/document/view/yhnze](https://fi-admin.bvsalud.org/document/view/yhnze)  
5. Genetic Diversity of Pectobacterium spp. on Potato in Serbia \- MDPI, accessed September 7, 2025, [https://www.mdpi.com/2076-2607/10/9/1840](https://www.mdpi.com/2076-2607/10/9/1840)  
6. pmc.ncbi.nlm.nih.gov, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC9769974/\#:\~:text=The%20SRP%20includes%20the%20two,and%20postharvest%20losses%20in%20a](https://pmc.ncbi.nlm.nih.gov/articles/PMC9769974/#:~:text=The%20SRP%20includes%20the%20two,and%20postharvest%20losses%20in%20a)  
7. The Discovery, Mechanisms, and Evolutionary Impact of Anti ..., accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC6039114/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6039114/)  
8. Experimental evidence for proteins constituting virion components and particle morphogenesis of bacteriophage ZF40, accessed September 7, 2025, [https://academic.oup.com/femsle/article-pdf/doi/10.1093/femsle/fnw042/23928678/fnw042.pdf](https://academic.oup.com/femsle/article-pdf/doi/10.1093/femsle/fnw042/23928678/fnw042.pdf)  
9. Pectobacterium phage ZF40 \- (www.genome.jp)., accessed September 7, 2025, [https://www.genome.jp/virushostdb/1127516](https://www.genome.jp/virushostdb/1127516)  
10. 7VJO: Pectobacterium phage ZF40 apo-Aca2 \- RCSB PDB, accessed September 7, 2025, [https://www.rcsb.org/pdb/explore/explore.do?structureId=7vjo](https://www.rcsb.org/pdb/explore/explore.do?structureId=7vjo)  
11. Structural insights into the inactivation of the type I-F CRISPR-Cas ..., accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC8782179/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8782179/)  
12. Tailed Lytic Bacteriophages of Soft Rot Pectobacteriaceae \- PMC \- PubMed Central, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC8472413/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8472413/)  
13. RefSeq: YP\_007006950 \- GenomeNet, accessed September 7, 2025, [https://www.genome.jp/dbget-bin/www\_bget?rs:YP\_007006950](https://www.genome.jp/dbget-bin/www_bget?rs:YP_007006950)  
14. Putative head protein \- Pectobacterium phage ZF40 (Bacteriophage ZF40) | UniProtKB | UniProt \- Bioregistry, accessed September 7, 2025, [https://bioregistry.io/uniprot:H9C193](https://bioregistry.io/uniprot:H9C193)  
15. Pectobacterium atrosepticum and Pectobacterium carotovorum Harbor Distinct, Independently Acquired Integrative and Conjugative Elements Encoding Coronafacic Acid that Enhance Virulence on Potato Stems \- Frontiers, accessed September 7, 2025, [https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2016.00397/full](https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2016.00397/full)  
16. The Bacterial Soft Rot Pathogens, Pectobacterium carotovorum and P. atrosepticum, Respond to Different Classes of Virulence-Inducing Host Chemical Signals \- MDPI, accessed September 7, 2025, [https://www.mdpi.com/2311-7524/6/1/13](https://www.mdpi.com/2311-7524/6/1/13)  
17. Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies \- PMC, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC8510557/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8510557/)  
18. Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors \- Innovative Genomics Institute, accessed September 7, 2025, [https://innovativegenomics.org/wp-content/uploads/2024/08/Li-Bondy-Denomy-2021.pdf](https://innovativegenomics.org/wp-content/uploads/2024/08/Li-Bondy-Denomy-2021.pdf)  
19. Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system \- Oxford Academic, accessed September 7, 2025, [https://academic.oup.com/nar/article/51/22/12381/7335753](https://academic.oup.com/nar/article/51/22/12381/7335753)  
20. Types I and V Anti-CRISPR Proteins: From Phage Defense to Eukaryotic Synthetic Gene Circuits \- PubMed Central, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC7556299/](https://pmc.ncbi.nlm.nih.gov/articles/PMC7556299/)  
21. EMDB-21359: Type I-F CRISPR-Csy complex with its inhibitor AcrF8 \- Yorodumi, accessed September 7, 2025, [https://pdbj.org/emnavi/quick.php?id=EMD-21359](https://pdbj.org/emnavi/quick.php?id=EMD-21359)  
22. Structural and mechanistic insights into the inhibition of type I-F CRISPR-Cas system by anti-CRISPR protein AcrIF23 \- ResearchGate, accessed September 7, 2025, [https://www.researchgate.net/publication/361234081\_Structural\_and\_mechanistic\_insights\_into\_the\_inhibition\_of\_type\_I-F\_CRISPR-Cas\_system\_by\_anti-CRISPR\_protein\_AcrIF23](https://www.researchgate.net/publication/361234081_Structural_and_mechanistic_insights_into_the_inhibition_of_type_I-F_CRISPR-Cas_system_by_anti-CRISPR_protein_AcrIF23)  
23. Structural and mechanistic insights into the CRISPR inhibition of AcrIF7 \- Oxford Academic, accessed September 7, 2025, [https://academic.oup.com/nar/article/48/17/9959/5893973](https://academic.oup.com/nar/article/48/17/9959/5893973)  
24. Structural basis of AcrIF24 as an anti-CRISPR protein and transcriptional suppressor \- PMC, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC9691602/](https://pmc.ncbi.nlm.nih.gov/articles/PMC9691602/)  
25. CRISPR-Cas Systems: Bridging Bacterial Immunity and Host Interactions\[v1\] | Preprints.org, accessed September 7, 2025, [https://www.preprints.org/manuscript/202509.0343/v1](https://www.preprints.org/manuscript/202509.0343/v1)  
26. Machine learning predicts new anti-CRISPR proteins \- Oxford Academic, accessed September 7, 2025, [https://academic.oup.com/nar/article/48/9/4698/5819938](https://academic.oup.com/nar/article/48/9/4698/5819938)  
27. Anti-CRISPR \- Wikipedia, accessed September 7, 2025, [https://en.wikipedia.org/wiki/Anti-CRISPR](https://en.wikipedia.org/wiki/Anti-CRISPR)  
28. Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against type I-F CRISPR–Cas complex revealed by cryo-EM (Journal Article) | OSTI.GOV, accessed September 7, 2025, [https://www.osti.gov/pages/biblio/1616844](https://www.osti.gov/pages/biblio/1616844)  
29. Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against type I-F CRISPR-Cas complex revealed by cryo-EM \- PubMed, accessed September 7, 2025, [https://pubmed.ncbi.nlm.nih.gov/32170016/](https://pubmed.ncbi.nlm.nih.gov/32170016/)  
30. EMDR : EMD-21359 \- EMDataResource, accessed September 7, 2025, [https://www.emdataresource.org/EMD-21359](https://www.emdataresource.org/EMD-21359)  
31. 6VQW \- NAKB, accessed September 7, 2025, [https://nakb.org/atlas=6VQW](https://nakb.org/atlas=6VQW)  
32. PDB Entry \- 6VQW (pdb\_00006vqw) \- wwPDB, accessed September 7, 2025, [https://www.wwpdb.org/pdb?id=pdb\_00006vqw](https://www.wwpdb.org/pdb?id=pdb_00006vqw)  
33. Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins \- PubMed, accessed September 7, 2025, [https://pubmed.ncbi.nlm.nih.gov/34606423/](https://pubmed.ncbi.nlm.nih.gov/34606423/)  
34. Anti-CRISPR proteins trigger a burst of CRISPR-Cas9 expression that enhances phage defense | bioRxiv, accessed September 7, 2025, [https://www.biorxiv.org/content/10.1101/2023.10.22.562561v1.full-text](https://www.biorxiv.org/content/10.1101/2023.10.22.562561v1.full-text)  
35. Crystal structure of the anti-CRISPR repressor Aca2 \- Durham Research Online, accessed September 7, 2025, [https://durham-repository.worktribe.com/output/1247345/crystal-structure-of-the-anti-crispr-repressor-aca2](https://durham-repository.worktribe.com/output/1247345/crystal-structure-of-the-anti-crispr-repressor-aca2)  
36. Molecular basis of anti-CRISPR operon repression by Aca10 \- ResearchGate, accessed September 7, 2025, [https://www.researchgate.net/publication/362455001\_Molecular\_basis\_of\_anti-CRISPR\_operon\_repression\_by\_Aca10](https://www.researchgate.net/publication/362455001_Molecular_basis_of_anti-CRISPR_operon_repression_by_Aca10)  
37. A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing \- PMC \- PubMed Central, accessed September 7, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC10328345/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10328345/)  
38. A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing \- Frontiers, accessed September 7, 2025, [https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2023.1164461/full](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2023.1164461/full)  
39. Types I and V Anti-CRISPR Proteins: From Phage Defense to Eukaryotic Synthetic Gene Circuits \- Frontiers, accessed September 7, 2025, [https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2020.575393/full](https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2020.575393/full)